전남대학교 중앙도서관

  • 중앙도서관
  • 여수캠퍼스도서관
  • 법학도서관
  • 치의학도서관
  • 의학도서관

링크메뉴

  • 화면키우기 화면줄이기 화면크기 원래대로
  • S
  • HOME
  • 로그인
  • 전남대
  • ENG
  • CHN

주메뉴

전체메뉴

전자자료 상세검색

전자자료 상세검색

통합검색
상세검색
검색어 [키워드: "Leung, SCY"]
총 20건 
※ 중복 레코드가 제거된 검색 결과가 표시됩니다.
1/2 페이지 RSS 엑셀파일 출력
검색결과수정
  • 검색범위확장
    • Full Text내 키워드 확장
    • 관련 주제어 확장

    재검색

  • 검색결과제한
    • 원문(Full Text)
    • Peer-Reviewed 학술지
    • 발행년 -

    재검색

  • 자료유형
    • Academic Journals (20)

    재검색

  • 주제
    • breast neoplasms (9)
    • ki-67 antigen (4)
    • ovarian neoplasms (4)

    더보기

    재검색

  • 간행물
    • histopathology (3)
    • breast cancer research and treatment (2)
    • cancers (2)

    더보기

    재검색

  • 출판사
    • blackwell scientific publications (3)
    • elsevier inc (3)
    • breast cancer research foundation (2)

    더보기

    재검색

  • 언어
    • english (18)

    재검색

  • 수록데이터베이스
    • MEDLINE (18)
    • eScholarship (2)

    재검색

  • PQDTSearch
  • CAJSearch
  • RISSSearch
  • PsycINFOSearch

 

3
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas. 미리보기

학술저널

issue
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 01; Vol. 29 (17), pp. 3471-3483.
Author
Heinze K; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; OVCARE - British Columbia's Gynecological Cancer Research Program, BC Cancer, Vancouver General Hospital, and the University of British Columbia, Vancouver, British Columbia, Canada.
Cairns ES; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.
Thornton S; OVCARE - British Columbia's Gynecological Cancer Research Program, BC Cancer, Vancouver General Hospital, and the University of British Columbia, Vancouver, British Columbia, Canada.; Molecular and Cellular Immunology Core (MCIC), Deeley Research Centre, BC Cancer, Victoria, Canada.
Harris B; Molecular and Cellular Immunology Core (MCIC), Deeley Research Centre, BC Cancer, Victoria, Canada.
Milne K; Molecular and Cellular Immunology Core (MCIC), Deeley Research Centre, BC Cancer, Victoria, Canada.
Grube M; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
Meyer C; OVCARE - British Columbia's Gynecological Cancer Research Program, BC Cancer, Vancouver General Hospital, and the University of British Columbia, Vancouver, British Columbia, Canada.; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
Karnezis AN; Department of Pathology and Laboratory, UC Davis Medical Center, Sacramento, California.
Fereday S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
Garsed DW; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
Leung SCY; OVCARE - British Columbia's Gynecological Cancer Research Program, BC Cancer, Vancouver General Hospital, and the University of British Columbia, Vancouver, British Columbia, Canada.
Chiu DS; OVCARE - British Columbia's Gynecological Cancer Research Program, BC Cancer, Vancouver General Hospital, and the University of British Columbia, Vancouver, British Columbia, Canada.
Moubarak M; Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany.
Harter P; Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany.
Heitz F; Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany.; Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
McAlpine JN; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; OVCARE - British Columbia's Gynecological Cancer Research Program, BC Cancer, Vancouver General Hospital, and the University of British Columbia, Vancouver, British Columbia, Canada.
DeFazio A; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
Bowtell DDL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
Goode EL; Mayo Clinic, Department of Health Science Research, Division of Epidemiology, Rochester, Minnesota.
Pike M; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Ramus SJ; School of Clinical Medicine, UNSW Medicine and Health, University of New South Wales Sydney, Sydney, Australia.; Multidisciplinary Ovarian Cancer Outcomes Group (Consortium).
Pearce CL; Multidisciplinary Ovarian Cancer Outcomes Group (Consortium).; School of Public Health, University of Michigan, Ann Arbor, Michigan.
Staebler A; Institute of Pathology, University Hospital of Tübingen, Tübingen, Germany.
Köbel M; Department of Pathology, University of Calgary, Calgary, Alberta, Canada.
Kommoss S; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
Talhouk A; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; OVCARE - British Columbia's Gynecological Cancer Research Program, BC Cancer, Vancouver General Hospital, and the University of British Columbia, Vancouver, British Columbia, Canada.
Nelson BH; OVCARE - British Columbia's Gynecological Cancer Research Program, BC Cancer, Vancouver General Hospital, and the University of British Columbia, Vancouver, British Columbia, Canada.; Molecular and Cellular Immunology Core (MCIC), Deeley Research Centre, BC Cancer, Victoria, Canada.; Multidisciplinary Ovarian Cancer Outcomes Group (Consortium).
Anglesio MS; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; OVCARE - British Columbia's Gynecological Cancer Research Program, BC Cancer, Vancouver General Hospital, and the University of British Columbia, Vancouver, British Columbia, Canada.
DB Label
Database : MEDLINE
원문보기
Full Text (AACR)  등재 - Web of Science (SCIE)  조회 - Impact Factor (JCR) 
4
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study. 미리보기

학술저널

issue
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2022 Oct; Vol. 35 (10), pp. 1362-1369. Date of Electronic Publication: 2022 Jun 21.
Author
Acs B; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. balazs.acs@ki.se.; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden. balazs.acs@ki.se.; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden. balazs.acs@ki.se.
Leung SCY; University of British Columbia, Vancouver, BC, Canada.
Kidwell KM; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Arun I; Tata Medical Center, Kolkata, West Bengal, India.
Augulis R; Vilnius University Faculty of Medicine and National Center of Pathology, Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania.
Badve SS; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Bai Y; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
Bane AL; Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada.
Bartlett JMS; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom.
Bayani J; Ontario Institute for Cancer Research, Toronto, ON, Canada.
Bigras G; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
Blank A; Institute of Pathology, University of Bern, Bern, Switzerland.; Institute of Pathology, Triemli Hospital Zurich, Zurich, Switzerland.
Buikema H; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Chang MC; Department of Pathology & Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, USA.
Dietz RL; Department of Pathology, Olive View-UCLA Medical Center, Los Angeles, CA, USA.
Dodson A; UK NEQAS for Immunocytochemistry and In-Situ Hybridisation, London, United Kingdom.
Fineberg S; Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY, USA.
Focke CM; Dietrich-Bonhoeffer Medical Center, Neubrandenburg, Mecklenburg-Vorpommern, Germany.
Gao D; University of British Columbia, Vancouver, BC, Canada.
Gown AM; PhenoPath Laboratories, Seattle, WA, USA.
Gutierrez C; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Hartman J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
Kos Z; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Lænkholm AV; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.
Laurinavicius A; Vilnius University Faculty of Medicine and National Center of Pathology, Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania.
Levenson RM; Department of Medical Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento, CA, USA.
Mahboubi-Ardakani R; Department of Medical Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento, CA, USA.
Mastropasqua MG; European Institute of Oncology, Milan, Italy.
Nofech-Mozes S; University of Toronto Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Osborne CK; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Penault-Llorca FM; Imagerie Moléculaire et Stratégies Théranostiques, UMR1240, Université Clermont Auvergne, INSERM, Clermont-Ferrand, France.; Service de Pathologie, Centre Jean PERRIN, Clermont-Ferrand, France.
Piper T; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom.
Quintayo MA; Ontario Institute for Cancer Research, Toronto, ON, Canada.
Rau TT; Institute of Pathology, University of Bern, Bern, Switzerland.; Institute of Pathology, Heinrich Heine University and University Hospital of Duesseldorf, Duesseldorf, Germany.
Reinhard S; Institute of Pathology, University of Bern, Bern, Switzerland.
Robertson S; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
Salgado R; Department of Pathology, GZA-ZNA, Antwerp, Belgium.; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
Sugie T; Kansai Medical University, Hirakata, Osaka, Japan.
van der Vegt B; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Viale G; European Institute of Oncology, Milan, Italy.; European Institute of Oncology IRCCS, and University of Milan, Milan, Italy.
Zabaglo LA; The Institute of Cancer Research, London, United Kingdom.
Hayes DF; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
Dowsett M; The Institute of Cancer Research, London, United Kingdom.
Nielsen TO; University of British Columbia, Vancouver, BC, Canada.
Rimm DL; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. david.rimm@yale.edu.
DB Label
Database : MEDLINE
원문보기
Full Text (ScienceDirect O/A)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
7
Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer. 미리보기

학술저널

issue
NPJ breast cancer [NPJ Breast Cancer] 2021 Sep 09; Vol. 7 (1), pp. 114. Date of Electronic Publication: 2021 Sep 09.
Author
Asleh K; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.; Interdisciplinary Oncology Program, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Riaz N; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.; Centre for Regenerative Medicine and Stem Cell Research, Aga Khan University, Karachi, Pakistan.
Cheng AS; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Gao D; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Leung SCY; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Anurag M; Baylor College of Medicine, Houston, TX, USA.
Nielsen TO; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. torsten@mail.ubc.ca.
DB Label
Database : MEDLINE
원문보기
OA (Springer)  Open Access (PubMed Central)  OA (Nature)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
9
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group. 미리보기

학술저널

issue
Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jul 01; Vol. 113 (7), pp. 808-819.
Author
Nielsen TO; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Leung SCY; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Rimm DL; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
Dodson A; The UK National External Quality Assessment Scheme for Immunocytochemistry and In-Situ Hybridisation, London, UK.
Acs B; Department of Oncology and Pathology, Cancer Centre Karolinska (CCK), Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pathology and Cytology, Karolinska University Laboratory, Stockholm, Sweden.
Badve S; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA.
Denkert C; Philipps University Marburg and University Hospital Marburg, Marburg, Germany.
Ellis MJ; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
Fineberg S; Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY, USA.
Flowers M; Breast Cancer Research Foundation, New York, NY, USA.
Kreipe HH; Medical School Hannover, Institute of Pathology, Hannover, Germany.
Laenkholm AV; Department of Surgical Pathology, Zealand University Hospital, Slagelse, Denmark.
Pan H; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Penault-Llorca FM; Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France.
Polley MY; Department of Public Health Sciences, University of Chicago Biological Sciences, Chicago, IL, USA.
Salgado R; Department of Pathology, GasthuisZusters Antwerpen / Hospital Network Antwerp (GZA-ZNA), Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
Smith IE; Breast Unit, Royal Marsden Hospital, London, UK.
Sugie T; Department of Surgery, Kansai Medical University, Shinmachi, Hirakata City, Osaka Prefecture, Japan.
Bartlett JMS; Diagnostic Development Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.
McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Dowsett M; Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK.
Hayes DF; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
DB Label
Database : MEDLINE
원문보기
Full Text (OUP)  등재 - Web of Science (SCIE)  조회 - Impact Factor (JCR) 
10
Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints. 미리보기

학술저널

issue
Cancers [Cancers (Basel)] 2021 Mar 01; Vol. 13 (5). Date of Electronic Publication: 2021 Mar 01.
Author
Chafe SC; Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada.
Riaz N; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.; Centre for Regenerative Medicine and Stem Cell Research, Aga Khan University, Sindh 74800, Pakistan.
Burugu S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.
Gao D; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.
Leung SCY; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.
Lee AF; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.
Lee CH; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.
Dedhar S; Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada.; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Nielsen TO; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.
DB Label
Database : MEDLINE
원문보기
Full Text Full Text (원문보기) Open Access (PubMed Central)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
1 2 
바구니보기

QUICK LINK

  • 희망도서신청
  • 대출/연장조회
  • 서가부재도서
  • 이용교육

마이메뉴추가

QRCode
  • 개인정보호정책
  • 이메일무단수집거부
  • 도서관이용문의

    • 도서관자치위원회  원격제어  Instagram  facebook  w  kakao 플친
500-757 광주광역시 북구 용봉로 77 TEL 062)530-3571~2(대출반납실) FAX 062)530-3529
Copyright@2013 CHONNAM NATIONAL UNIVERSITY LIBRARY, All Rights Reserved.
  • 186474
  • 128056978